Jason B. Fleming

Moffitt Cancer Center, University of South Florida

Papers

Total Citations

H-Index

About

Jason B. Fleming is a leading surgical oncologist whose research centers on optimizing outcomes for patients with gastrointestinal malignancies, with a particular focus on esophageal cancer. His major contributions lie in advancing robotic-assisted surgery and refining perioperative care pathways. In his landmark study, "Outcomes of 350 Robotic-assisted Esophagectomies at a High-volume Cancer Center" (26 citations), Fleming demonstrated that robotic-assisted minimally invasive esophagectomy (RAMIE) can achieve oncologic outcomes comparable to traditional open esophagectomy while potentially reducing morbidity, establishing a benchmark for high-volume centers. He further showed how integrating advanced practice providers with structured care pathways significantly reduces hospital stays after complex gastrointestinal cancer surgery (11 citations). Beyond these studies, Fleming is recognized for his leadership in surgical quality improvement and multidisciplinary cancer care. His work directly impacts clinical practice by providing evidence for adopting robotic techniques and streamlining recovery protocols, making him a key figure in modernizing surgical oncology.